Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes.
Saved in:
| Title: | Real-World Evidence of Omnipod® 5 Automated Insulin Delivery System Use in 69,902 People with Type 1 Diabetes. |
|---|---|
| Authors: | Forlenza GP; Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., DeSalvo DJ; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Aleppo G; Division of Endocrinology, Metabolism, and Molecular Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA., Wilmot EG; Translational Medical Sciences, University of Nottingham, School of Medicine, Royal Derby Hospital, Derby, United Kingdom., Berget C; Department of Pediatrics, Barbara Davis Center for Diabetes, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA., Huyett LM; Insulet Corporation, Acton, Massachusetts, USA., Hadjiyianni I; Insulet Corporation, Acton, Massachusetts, USA., Méndez JJ; Insulet Corporation, Acton, Massachusetts, USA., Conroy LR; Insulet Corporation, Acton, Massachusetts, USA., Ly TT; Insulet Corporation, Acton, Massachusetts, USA., Sherr JL; Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA. |
| Source: | Diabetes technology & therapeutics [Diabetes Technol Ther] 2024 Aug; Vol. 26 (8), pp. 514-525. Date of Electronic Publication: 2024 Feb 16. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8593 (Electronic) Linking ISSN: 15209156 NLM ISO Abbreviation: Diabetes Technol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
